ABCG5
Basic information
Region (hg38): 2:43812472-43838865
Links
Phenotypes
GenCC
Source:
- sitosterolemia 1 (Definitive), mode of inheritance: AR
- sitosterolemia (Supportive), mode of inheritance: AR
- sitosterolemia 1 (Strong), mode of inheritance: AR
- sitosterolemia 1 (Definitive), mode of inheritance: AR
- sitosterolemia (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Sitosterolemia 2 | AR | Biochemical; Cardiovascular | In some individuals, medical (eg, with bile acid resins/lipid-lowering agents) and dietary (eg, with cholesterol and plant fat restriction) treatment may be beneficial for some parameters, and may, along with preventive measures related to cardiovascular manifestations, reduce morbidity and mortality | Biochemical; Cardiovascular; Hematologic | 11099417; 11138003; 12840092; 16029460; 16472606; 17018391; 17785700; 17976197; 19111681; 20521169; 20543520; 20719861; 21576934; 24166850; 31901240 |
ClinVar
This is a list of variants' phenotypes submitted to
- Sitosterolemia (12 variants)
- Cardiovascular phenotype (6 variants)
- not provided (3 variants)
- Sitosterolemia 2 (2 variants)
- Abnormal circulating lipid concentration (1 variants)
- Hypercholesterolemia (1 variants)
- ABCG5-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ABCG5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | 112 | 123 | |||
missense | 268 | 280 | ||||
nonsense | 10 | 13 | ||||
start loss | 2 | |||||
frameshift | 11 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 11 | |||||
splice region | 12 | 12 | 24 | |||
non coding | 13 | 56 | 34 | 103 | ||
Total | 20 | 16 | 298 | 176 | 35 |
Highest pathogenic variant AF is 0.0000197
Variants in ABCG5
This is a list of pathogenic ClinVar variants found in the ABCG5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-43812494-G-A | Sitosterolemia 1 | Benign (Jan 13, 2018) | ||
2-43812495-G-A | Sitosterolemia 1 | Uncertain significance (Jan 12, 2018) | ||
2-43812524-C-T | Sitosterolemia 1 | Uncertain significance (Jan 12, 2018) | ||
2-43812581-G-A | Sitosterolemia 1 | Benign (Apr 27, 2017) | ||
2-43812594-C-T | Sitosterolemia 1 | Benign (Jan 13, 2018) | ||
2-43812605-G-T | Sitosterolemia 1 | Uncertain significance (Jan 13, 2018) | ||
2-43812700-C-T | Sitosterolemia 1 | Benign (Jan 13, 2018) | ||
2-43812717-G-A | Sitosterolemia 1 | Benign (Jan 12, 2018) | ||
2-43812736-A-C | Sitosterolemia 1 | Benign (Apr 19, 2019) | ||
2-43812758-T-TA | Sitosterolemia | Uncertain significance (Jun 14, 2016) | ||
2-43812764-A-G | Sitosterolemia 1 | Uncertain significance (Jan 13, 2018) | ||
2-43812831-C-G | Sitosterolemia 1 | Conflicting classifications of pathogenicity (Feb 01, 2023) | ||
2-43812891-C-A | Sitosterolemia 1 | Uncertain significance (Jan 13, 2018) | ||
2-43812963-G-T | Sitosterolemia 1 | Uncertain significance (Jan 12, 2018) | ||
2-43813044-C-T | Likely benign (Oct 07, 2019) | |||
2-43813120-C-T | Cardiovascular phenotype | Uncertain significance (Sep 26, 2022) | ||
2-43813122-G-A | Uncertain significance (May 30, 2018) | |||
2-43813127-T-G | Cardiovascular phenotype | Uncertain significance (Apr 07, 2023) | ||
2-43813130-G-A | Cardiovascular phenotype | Uncertain significance (Jul 13, 2023) | ||
2-43813139-T-C | Cardiovascular phenotype | Uncertain significance (May 23, 2024) | ||
2-43813159-C-T | Sitosterolemia | Uncertain significance (Jul 08, 2023) | ||
2-43813162-A-G | not specified | Uncertain significance (Jul 18, 2023) | ||
2-43813168-A-C | Cardiovascular phenotype | Uncertain significance (Jan 16, 2024) | ||
2-43813168-A-G | Sitosterolemia 1 | Uncertain significance (Jan 13, 2018) | ||
2-43813174-G-C | Cardiovascular phenotype | Uncertain significance (Oct 19, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ABCG5 | protein_coding | protein_coding | ENST00000260645 | 13 | 26394 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.08e-21 | 0.00109 | 125609 | 0 | 139 | 125748 | 0.000553 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.744 | 410 | 370 | 1.11 | 0.0000223 | 4218 |
Missense in Polyphen | 136 | 121.35 | 1.1207 | 1451 | ||
Synonymous | -1.48 | 179 | 156 | 1.15 | 0.0000102 | 1349 |
Loss of Function | -0.133 | 31 | 30.2 | 1.03 | 0.00000176 | 333 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000804 | 0.000803 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00223 | 0.00223 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000371 | 0.000369 |
Middle Eastern | 0.00223 | 0.00223 |
South Asian | 0.000981 | 0.000980 |
Other | 0.000327 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: ABCG5 and ABCG8 form an obligate heterodimer that mediates Mg(2+)- and ATP-dependent sterol transport across the cell membrane (PubMed:27144356). Plays an essential role in the selective transport of dietary plant sterols and cholesterol in and out of the enterocytes and in the selective sterol excretion by the liver into bile (PubMed:11099417, PubMed:11138003, PubMed:27144356, PubMed:15054092). Required for normal sterol homeostasis (PubMed:11099417, PubMed:11138003, PubMed:15054092). The heterodimer with ABCG8 has ATPase activity (PubMed:16893193, PubMed:20210363, PubMed:27144356). {ECO:0000269|PubMed:11138003, ECO:0000269|PubMed:15054092, ECO:0000269|PubMed:16893193, ECO:0000269|PubMed:20210363, ECO:0000269|PubMed:27144356, ECO:0000303|PubMed:11590207, ECO:0000305|PubMed:11099417}.;
- Disease
- DISEASE: Sitosterolemia (STSL) [MIM:210250]: Rare autosomal recessive disorder characterized by increased intestinal absorption of all sterols including cholesterol, plant and shellfish sterols, and decreased biliary excretion of dietary sterols into bile. Sitosterolemia patients have hypercholesterolemia, very high levels of plant sterols in the plasma, and frequently develop tendon and tuberous xanthomas, accelerated atherosclerosis and premature coronary artery disease. {ECO:0000269|PubMed:11138003, ECO:0000269|PubMed:11452359, ECO:0000269|PubMed:11668628, ECO:0000269|PubMed:15054092}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Fat digestion and absorption - Homo sapiens (human);Bile secretion - Homo sapiens (human);ABC transporters - Homo sapiens (human);Cholesterol metabolism - Homo sapiens (human);Statin Pathway, Pharmacodynamics;Liver X Receptor Pathway;Nuclear Receptors Meta-Pathway;Nuclear Receptors in Lipid Metabolism and Toxicity;Angiopoietin Like Protein 8 Regulatory Pathway;Liver steatosis AOP;Statin Pathway;Vitamin A and Carotenoid Metabolism;ABC transporters in lipid homeostasis;Transport of small molecules;C21-steroid hormone biosynthesis and metabolism;ABC-family proteins mediated transport
(Consensus)
Recessive Scores
- pRec
- 0.0867
Intolerance Scores
- loftool
- 0.359
- rvis_EVS
- 1.16
- rvis_percentile_EVS
- 92.65
Haploinsufficiency Scores
- pHI
- 0.103
- hipred
- N
- hipred_score
- 0.261
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.664
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Abcg5
- Phenotype
- muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; digestive/alimentary phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype;
Gene ontology
- Biological process
- drug transmembrane transport;response to nutrient;excretion;response to ionizing radiation;negative regulation of intestinal phytosterol absorption;intestinal cholesterol absorption;cholesterol efflux;cholesterol homeostasis;negative regulation of intestinal cholesterol absorption;transmembrane transport
- Cellular component
- plasma membrane;integral component of plasma membrane;apical plasma membrane;ATP-binding cassette (ABC) transporter complex;receptor complex
- Molecular function
- protein binding;ATP binding;ATPase activity;cholesterol transporter activity;ATPase activity, coupled to transmembrane movement of substances;metal ion binding;protein heterodimerization activity